γ-Tocotrienol inhibits HGF-dependent mitogenesis and Met activation in highly malignant mammary tumor cells

被引:0
|
作者
Ayoub, Nehad M. [1 ]
Bachawal, Sunitha V. [2 ]
Sylvester, Paul W. [1 ]
机构
[1] Univ Louisiana Monroe, Monroe, LA USA
[2] Stanford Univ, Stanford, CA 94305 USA
关键词
D O I
10.1158/1538-7445.AM2012-1088
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1088
引用
收藏
页数:2
相关论文
共 33 条
  • [1] γ-Tocotrienol inhibits HGF-dependent mitogenesis and Met activation in highly malignant mammary tumour cells
    Ayoub, N. M.
    Bachawal, S. V.
    Sylvester, P. W.
    CELL PROLIFERATION, 2011, 44 (06) : 516 - 526
  • [2] LY2875358, a Neutralizing and Internalizing Anti-MET Bivalent Antibody, Inhibits HGF-Dependent and HGF-Independent MET Activation and Tumor Growth
    Liu, Ling
    Zeng, Wei
    Wortinger, Mark A.
    Yan, S. Betty
    Cornwell, Paul
    Peek, Victoria L.
    Stephens, Jennifer R.
    Tetreault, Jonathan W.
    Xia, Jinqi
    Manro, Jason R.
    Credille, Kelly M.
    Ballard, Darryl W.
    Brown-Augsburger, Patricia
    Wacheck, Volker
    Chow, Chi-Kin
    Huang, Lihua
    Wang, Yong
    Denning, Irene
    Davies, Julian
    Tang, Ying
    Vaillancourt, Peter
    Lu, Jirong
    CLINICAL CANCER RESEARCH, 2014, 20 (23) : 6059 - 6070
  • [3] Novel xenograft model to study MET/HGF-dependent tumor progression.
    Francone, Todd D.
    Landmann, Ron G.
    Chen, Chin-Tung
    Kuntz, Eleanor
    Zeng, Zhaoshi
    Paty, Philip B.
    Weiser, Martin R.
    CANCER RESEARCH, 2006, 66 (08)
  • [4] Met overexpression confers HGF-dependent invasive phenotype to human thyroid carcinoma cells in vitro
    De Luca, A
    Arena, N
    Sena, LM
    Medico, E
    JOURNAL OF CELLULAR PHYSIOLOGY, 1999, 180 (03) : 365 - 371
  • [5] Dimer Interface in Natural Variant NK1 Is Dispensable for HGF-Dependent Met Receptor Activation
    Tahira, Yumiko
    Sakai, Katsuya
    Sato, Hiroki
    Imamura, Ryu
    Matsumoto, Kunio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)
  • [6] Gamma-tocotrienol induces autophagy in malignant mammary tumor cells
    Tiwari, R. V.
    Parajuli, P.
    Sylvester, P. W.
    CANCER RESEARCH, 2013, 73
  • [7] Protease inhibitors of HGF activation prevent HGF-dependent tumor progression and overcome resistance to anti-cancer therapy
    Voss, Jorine J. L. P.
    Damalanka, Vishnu
    Mahoney, Matthew
    Klampfer, Lidija
    Janetka, James W.
    CANCER RESEARCH, 2021, 81 (05)
  • [8] MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM
    Casaletto, Jessica B.
    Geddie, Melissa L.
    Abu-Yousif, Adnan O.
    Masson, Kristina
    Fulgham, Aaron
    Boudot, Antoine
    Maiwald, Tim
    Kearns, Jeffrey D.
    Kohli, Neeraj
    Su, Stephen
    Razlog, Maja
    Raue, Andreas
    Kalra, Ashish
    Hakansson, Maria
    Logan, Derek T.
    Welin, Martin
    Chattopadhyay, Shrikanta
    Harms, Brian D.
    Nielsen, Ulrik B.
    Schoeberl, Birgit
    Lugovskoy, Alexey A.
    MacBeath, Gavin
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (15) : 7533 - 7542
  • [9] γ-Tocotrienol inhibition of metastatic phenotypic behavior is associated with a decrease in galectin-3 expression and distribution in the highly malignant mouse plus SA & TS/A mammary tumor cells
    Sylvester, Paul W.
    Grazier, Jessie J.
    CANCER RESEARCH, 2022, 82 (12)
  • [10] γ-Tocotrienol inhibition of metastatic phenotypic behavior is associated with a decrease in galectin-3 expression and distribution in the highly malignant mouse plus SA & TS/A mammary tumor cells.
    Grazier, Jessie J.
    Sylvester, Paul W.
    CANCER RESEARCH, 2021, 81 (13)